JULIE HINOJOSA: Open Payments
NPI 1760738538 · PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 20 payments from 11 companies in 2025. Trend: 2023 $598 · 2024 $796 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $155 |
| Janssen Biotech, Inc. | 4 | $97 |
| UCB, Inc. | 3 | $95 |
| Amgen Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $40 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, OTEZLA, ISTURISA, COSENTYX, QULIPTA, Ozempic.
Industry payments across FL — which companies pay providers there.
